IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Type I interferons (IFNs) play an essential role in the host response to viral infection through the induction of numerous IFN-stimulated genes (ISGs), including important antiviral molecules such as PKR, RNase L, Mx, and iNOS. Yet, additional antiviral ISGs likely exist. IFN-stimulated gene 15 (ISG15) is a ubiquitin homolog that is rapidly up-regulated after viral infection, and it conjugates to a wide array of host proteins. Although it has been hypothesized that ISG15 functions as an antiviral molecule, the initial evaluation of ISG15-deficient mice revealed no defects in their responses to vesicular stomatitis virus or lymphocytic choriomeningitis virus, leaving open the important question of whether ISG15 is an antiviral molecule in vivo . Here we demonstrate that ISG15 is critical for the host response to viral infection. ISG15 −/− mice are more susceptible to influenza A/WSN/33 and influenza B/Lee/40 virus infections. ISG15 −/− mice also exhibited increased susceptibility to both herpes simplex virus type 1 and murine gammaherpesvirus 68 infection and to Sindbis virus infection. The increased susceptibility of ISG15 −/− mice to Sindbis virus infection was rescued by expressing wild-type ISG15, but not a mutant form of ISG15 that cannot form conjugates, from the Sindbis virus genome. The demonstration of ISG15 as a novel antiviral molecule with activity against both RNA and DNA viruses provides a target for the development of therapies against important human pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Generation of influenza A viruses entirely from cloned cDNAs
Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P., Hughes, M., Perez, D. R., Donis, R., Hoffmann, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9345 · Cited by 1,278
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
A critical function for type I interferons in cancer immunoediting
Dunn, G. P., Bruce, A. T., Sheehan, K. C. F., Shankaran, V., Uppaluri, R., Bui, J. D., Diamond, M. S., Koebel, C. M., Arthur, C., White, J. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1213 · Cited by 605
Foy, E., Li, K., Sumpter, R., Loo, Y.-M., Johnson, C. L., Wang, C., Fish, P. M., Yoneyama, M., Fujita, T., Lemon, S. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408707102 · Cited by 548
Yuan, W. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.362 · Cited by 529
Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S., & Krug, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504754102 · Cited by 472
Immunoregulatory properties of ISG15, an interferon-induced cytokine.
D'Cunha, J., Knight, E., Haas, A. L., Truitt, R. L., & Borden, E. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.211 · Cited by 383
Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15
Okumura, A., Lu, G., Pitha-Rowe, I., & Pitha, P. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510518103 · Cited by 363
Zhao, C., Beaudenon, S. L., Kelley, M. L., Waddell, M. B., Yuan, W., Schulman, B. A., Huibregtse, J. M., & Krug, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402528101 · Cited by 329
Zou, W., & Zhang, D.-E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510787200 · Cited by 304
The Role of Interferon in Influenza Virus Tissue Tropism
García-Sastre, A., Durbin, R. K., Zheng, H., Palese, P., Gertner, R., Levy, D. E., & Durbin, J. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8550-8558.1998 · Cited by 286
Herc5, an Interferon-induced HECT E3 Enzyme, Is Required for Conjugation of ISG15 in Human Cells
Dastur, A., Beaudenon, S., Kelley, M., Krug, R. M., & Huibregtse, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512830200 · Cited by 283
Lenschow, D. J., Giannakopoulos, N. V., Gunn, L. J., Johnston, C., O'Guin, A. K., Schmidt, R. E., Levine, B., & Virgin, H. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13974-13983.2005 · Cited by 268
Self-citationInterferon Action in Triply Deficient Mice Reveals the Existence of Alternative Antiviral Pathways
Zhou, A., Paranjape, J. M., Der, S. D., Williams, B. R. G., & Silverman, R. H. (1999) · Virology · doi:10.1006/viro.1999.9738 · Cited by 244
Proteomic identification of proteins conjugated to ISG15 in mouse and human cells
Giannakopoulos, N. V., Luo, J.-K., Papov, V., Zou, W., Lenschow, D. J., Jacobs, B. S., Borden, E. C., Li, J., Virgin, H. W., & Zhang, D.-E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.132 · Cited by 235
Self-citationInterferon-Inducible Ubiquitin E2, Ubc8, Is a Conjugating Enzyme for Protein ISGylation
Kim, K. I., Giannakopoulos, N. V., Virgin, H. W., & Zhang, D.-E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9592-9600.2004 · Cited by 233
Self-citationSpecific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
Leib, D. A., Machalek, M. A., Williams, B. R. G., Silverman, R. H., & Virgin, H. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100415697 · Cited by 230
Self-citationCrystal Structure of the Interferon-induced Ubiquitin-like Protein ISG15
Narasimhan, J., Wang, M., Fu, Z., Klein, J. M., Haas, A. L., & Kim, J.-J. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502814200 · Cited by 229
In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine
D'Cunha, J., Ramanujam, S., Wagner, R. J., Witt, P. L., Knight, E., & Borden, E. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.4100 · Cited by 222
Osiak, A., Utermöhlen, O., Niendorf, S., Horak, I., & Knobeloch, K.-P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6338-6345.2005 · Cited by 213
Self-citationA human 15-kDa IFN-induced protein induces the secretion of IFN-gamma
Recht, M., Borden, E. C., & Knight, E. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2617 · Cited by 177
McCown, M. F., & Pekosz, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3595-3605.2005 · Cited by 177
Self-citationISG15: the immunological kin of ubiquitin
Ritchie, K. J., & Zhang, D. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.005 · Cited by 150
Nicholl, M. J., Robinson, L. H., & Preston, C. M. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-9-2215 · Cited by 143
Dauber, B., Heins, G., & Wolff, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1865-1872.2004 · Cited by 113
Self-citationIdentification of a ubiquitin family protein as a novel neutrophil chemotactic factor
Owhashi, M., Taoka, Y., Ishii, K., Nakazawa, S., Uemura, H., & Kambara, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.038 · Cited by 111
Padovan, E., Terracciano, L., Certa, U., Jacobs, B., Reschner, A., Bolli, M., Spagnoli, G. C., Borden, E. C., & Heberer, M. (2002) · PubMed · Cited by 109
Barton, E. S., Lutzke, M. L., Rochford, R. A., & Virgin, H. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14149-14160.2005 · Cited by 101
Self-citationReexamination of the Role of Ubiquitin-Like Modifier ISG15 in the Phenotype of UBP43-Deficient Mice
Knobeloch, K.-P., Utermöhlen, O., Kisser, A., Prinz, M., & Horak, I. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11030-11034.2005 · Cited by 101
Self-citation
Cited by
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
“ISG15 inhibits HIv1 release from cells, mimicking the effect of IFN 108 and infections by influenza, herpes and Sindbis viruses 109 .”
Innate immunity to influenza virus infection
Iwasaki, A., & Pillai, P. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3665 · Cited by 1,068
Metadata
- Authors
- Lenschow, D. J., Lai, C., Frias-Staheli, N., Giannakopoulos, N. V., Lutz, A., Wolff, T., Osiak, A., Levine, B., Schmidt, R. E., García-Sastre, A., Leib, D. A., Pekosz, A., Knobeloch, K.-P., Horak, I., & Virgin, H. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-01-23
- Volume
- 104
- Issue
- 4
- Pages
- 1371-1376
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2129415910
- Cited by
- 557
- References
- 31
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.